Literature DB >> 27665034

Epidemiology and economic impact of health care-associated infections and cost-effectiveness of infection control measures at a Thai university hospital.

Pinyo Rattanaumpawan1, Visanu Thamlikitkul2.   

Abstract

BACKGROUND: Data on clinical and economic impact of health care-associated infections (HAIs) from resource limited countries are limited. We aimed to determine epidemiology and economic impact of HAIs and cost-effectiveness of infection prevention and control measures in a resource-limited setting.
METHODS: A retrospective cohort study was conducted among hospitalized patients at Siriraj Hospital, Thailand. Results from the cohort were subsequently used to conduct cost-effective analysis (CEA) to compare the comprehensive implementation of individualized bundling infection control measures (IBICMs) with regular infection control care.
RESULTS: From February-May 2013, there were 515 hospitalizations (497 patients) with 7,848 hospitalization days. Cumulative incidence of HAIs was 23.30%, and the incidence rate of HAIs was 18.66 ± 44.19 per 1,000 hospitalization days. Hospital mortality among those with and without HAIs was 33.33% and 20.00%, respectively (P < .001). The adjusted cost attributable to HAIs was $704.72 ± $226.73 (P < .001). CEA identified IBICMs as a non-dominated strategy, with an incremental cost-effectiveness ratio of -$20,444.62 per life saved.
CONCLUSIONS: HAI is significantly related with higher hospital mortality, longer length of stay, and higher hospitalization costs. IBICMs were confirmed to be cost-effective at Siriraj Hospital. Implementing this intervention could improve care quality and save costs.
Copyright © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Health care–associated infection; Infection control

Mesh:

Year:  2016        PMID: 27665034     DOI: 10.1016/j.ajic.2016.07.018

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.

Authors:  Si-Ho Kim; Kyoung Ree Lim; Hyunju Lee; Kyungmin Huh; Sun Young Cho; Cheol-In Kang; Doo Ryeon Chung; Kyong Ran Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-13       Impact factor: 3.267

Review 2.  Cost-effectiveness of interventions to reduce the risk of healthcare-acquired infections in middle-income countries: A systematic review.

Authors:  Pushpa Udayangani Gamalathge; Sanjeewa Kularatna; Hannah E Carter; Sameera Senanayake; Nicholous Graves
Journal:  J Infect Prev       Date:  2019-06-04

3.  Utilization of a central venous catheter insertion care bundle in Taiwan: A cross-sectional analysis of the National Health Insurance Research Database.

Authors:  Hui-Chun Chung; Lih-Shinn Wang; Jung-Lun Wu; Tsung-Cheng Hsieh
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Jul-Sep

Review 4.  Safe Healthcare Facilities: A Systematic Review on the Costs of Establishing and Maintaining Environmental Health in Facilities in Low- and Middle-Income Countries.

Authors:  Darcy M Anderson; Ryan Cronk; Donald Fejfar; Emily Pak; Michelle Cawley; Jamie Bartram
Journal:  Int J Environ Res Public Health       Date:  2021-01-19       Impact factor: 3.390

5.  Knowledge, attitude and practice concerning healthcare-associated infections among healthcare workers in Wuhan, China: cross-sectional study.

Authors:  Wenwen Wu; Wenru Wang; Yufeng Yuan; Likai Lin; Yibin Tan; Jinru Yang; Li Dai; Ying Wang
Journal:  BMJ Open       Date:  2021-01-05       Impact factor: 2.692

6.  Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study.

Authors:  Rujipas Sirijatuphat; Sunee Chayangsu; Jintana Srisompong; Darat Ruangkriengsin; Visanu Thamlikitkul; Surapee Tiengrim; Walaiporn Wangchinda; Pornpan Koomanachai; Pinyo Rattanaumpawan
Journal:  Antibiotics (Basel)       Date:  2022-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.